Samples for study ST001751
Species: Mus musculus (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | hours | Sample_Data:RAW_FILE_NAME |
|---|---|---|---|---|
| SA163886 | - | VJ_17.05.13_2_#21 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_005 | 48 | treatment:CHX | concentration:20 µg/ml | VJ_17.05.13_2 |
| SA163887 | - | VJ_17.05.17_#21 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_005 | 48 | treatment:CHX | concentration:20 µg/ml | VJ_17.05.17 |
| SA163885 | - | VJ_17.05.17-n3_#21 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_005 | 48 | treatment:CHX | concentration:20 µg/ml | VJ_17.05.17-n3 |
| SA163889 | - | VJ_17.05.13_2_#22 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_006 | 48 | treatment:ETO | concentration:10 µM | VJ_17.05.13_2 |
| SA163888 | - | VJ_17.05.17_#22 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_006 | 48 | treatment:ETO | concentration:10 µM | VJ_17.05.17 |
| SA163890 | - | VJ_17.05.17-n3_#22 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_006 | 48 | treatment:ETO | concentration:10 µM | VJ_17.05.17-n3 |
| SA163891 | - | VJ_17.05.13_2_#27 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_011 | 48 | treatment:I3M | concentration:10 µM | VJ_17.05.13_2 |
| SA163892 | - | VJ_17.05.17_#27 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_011 | 48 | treatment:I3M | concentration:10 µM | VJ_17.05.17 |
| SA163893 | - | VJ_17.05.17-n3_#27 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_011 | 48 | treatment:I3M | concentration:10 µM | VJ_17.05.17-n3 |
| SA163895 | - | VJ_17.05.13_2_#26 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_010 | 48 | treatment:MC | concentration:10 µM | VJ_17.05.13_2 |
| SA163894 | - | VJ_17.05.17_#26 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_010 | 48 | treatment:MC | concentration:10 µM | VJ_17.05.17 |
| SA163896 | - | VJ_17.05.17-n3_#26 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_010 | 48 | treatment:MC | concentration:10 µM | VJ_17.05.17-n3 |
| SA163902 | - | VJ_17.05.13_2_#25 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_009 | 48 | treatment:Serum | concentration:- | VJ_17.05.13_2 |
| SA163900 | - | VJ_17.05.17_#25 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_009 | 48 | treatment:Serum | concentration:- | VJ_17.05.17 |
| SA163901 | - | VJ_17.05.17-n3_#25 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_009 | 48 | treatment:Serum | concentration:- | VJ_17.05.17-n3 |
| SA163898 | - | VJ_17.05.13_2_#20 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_004 | 48 | treatment:STS | concentration:0.3 µM | VJ_17.05.13_2 |
| SA163899 | - | VJ_17.05.17_#20 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_004 | 48 | treatment:STS | concentration:0.3 µM | VJ_17.05.17 |
| SA163897 | - | VJ_17.05.17-n3_#20 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_004 | 48 | treatment:STS | concentration:0.3 µM | VJ_17.05.17-n3 |
| SA163903 | - | VJ_17.05.13_2_#19 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_003 | 48 | treatment:TNFα | concentration:10 ng/ml | VJ_17.05.13_2 |
| SA163905 | - | VJ_17.05.17_#19 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_003 | 48 | treatment:TNFα | concentration:10 ng/ml | VJ_17.05.17 |
| SA163904 | - | VJ_17.05.17-n3_#19 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_003 | 48 | treatment:TNFα | concentration:10 ng/ml | VJ_17.05.17-n3 |
| SA163908 | - | VJ_17.05.13_2_#23 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_007 | 48 | treatment:TPG | concentration:2 µM | VJ_17.05.13_2 |
| SA163907 | - | VJ_17.05.17_#23 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_007 | 48 | treatment:TPG | concentration:2 µM | VJ_17.05.17 |
| SA163906 | - | VJ_17.05.17-n3_#23 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_007 | 48 | treatment:TPG | concentration:2 µM | VJ_17.05.17-n3 |
| SA163909 | - | VJ_17.05.13_2_#24 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_008 | 48 | treatment:VAL | concentration:10 µM | VJ_17.05.13_2 |
| SA163911 | - | VJ_17.05.17_#24 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_008 | 48 | treatment:VAL | concentration:10 µM | VJ_17.05.17 |
| SA163910 | - | VJ_17.05.17-n3_#24 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_008 | 48 | treatment:VAL | concentration:10 µM | VJ_17.05.17-n3 |
| SA163917 | - | VJ_17.05.13_2_#18 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_002 | 48 | treatment:vehicle (DMSO) | concentration:- | VJ_17.05.13_2 |
| SA163914 | - | VJ_17.05.13_2_#28 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_012 | 48 | treatment:vehicle (DMSO) | concentration:- | VJ_17.05.13_2 |
| SA163916 | - | VJ_17.05.17_#18 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_002 | 48 | treatment:vehicle (DMSO) | concentration:- | VJ_17.05.17 |
| SA163913 | - | VJ_17.05.17_#28 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_012 | 48 | treatment:vehicle (DMSO) | concentration:- | VJ_17.05.17 |
| SA163915 | - | VJ_17.05.17-n3_#18 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_002 | 48 | treatment:vehicle (DMSO) | concentration:- | VJ_17.05.17-n3 |
| SA163912 | - | VJ_17.05.17-n3_#28 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_012 | 48 | treatment:vehicle (DMSO) | concentration:- | VJ_17.05.17-n3 |
